Home › Neuroblastoma › Colorado
Pag-aaral pangklinika para sa Neuroblastoma sa Colorado
9 pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa mga site sa Colorado.
Mga Lungsod sa Colorado
Opisyal na teksto ng pag-aaral (English)
Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Children's Hospital Colorado, Aurora
Nagre-recruit
Hanggang edad 17 · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT06831552Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Hospital Colorado, Aurora
Nagre-recruitPhase 3
Hanggang edad 30 · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06172296Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Okt 30, 2026 · NCT06395103Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Hospital Colorado, Aurora
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
Nagre-recruitPhase 3
365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital Colorado, Aurora
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
- Children's Hospital Colorado, Aurora
Nagre-recruitPhase 2
Edad 1 hanggang 31 · Lahat ng kasarian · Na-update Hul 20, 2026 · NCT06450041Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Hospital Colorado, Aurora
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update May 19, 2026 · NCT04901702Neuroblastoma Biology Study
- Children Hospital of Colorado, Aurora
Nagre-recruitObservasyonal na pag-aaral
31 Days – 99 Years · Lahat ng kasarian · Na-update Mar 23, 2026 · NCT01587300A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital of Colorado, Aurora
Nagre-recruitPhase 2
18 Months – 40 Years · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT05135975Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.